诺和诺德：第三季度财报打破“内部蚕食”迷思 (NYSE:NVO)
· seekingalpha.com
诺和诺德第三季度业绩缓解了口服药物内部蚕食的担忧，股价潜在上涨空间达34%。本文阐述为何我目前对NVO股票持乐观态度。
The latest earnings for Novo Nordisk ( NVO ) confirm a trend that value investors have been watching out for since the company's Capital Markets Day on 21 Septe...